Literature DB >> 29262913

[Screening Abnormal Hemoglobin Diseases for Couples of Childbearing Age in Guangzhou City by HPLC].

Gui-Lan Chen1, Yan-Xia Qu2, Fan Jiang2, Ying Tang2, Fang Tang2, Lian-Dong Zuo2.   

Abstract

OBJECTIVE: To investigate the incidence and common types of abnormal hemoglobin diseases of the couples at childbearing age by using high performance liquid chromatography (HPLC) in Guangzhou city.
METHODS: The couple of childbearing age in the Birth defect intervention project and Free pre pregnancy health examination were screened from October 2008 to February 2016 in Guangzhou city. The HPLC was used to detect abnormal hemoglobin; The Gap-PCR and reverse dot blot(RDB) were used to detect thalassemia gene deletions.
RESULTS: The detection rate of hemoglobinopathies was 1.14% in the couples of childbearing age in Guangzhou city. 8 kinds of abnormal hemoglobin were detected: Hb E in 102 cases(17 cases with α thalassemia) , Hb Q-Thailand in 20 cases(18 cases with α thalassemia, 2 cases with α and β thalassemia), Hb D-Iran in 4 cases(2 cases with α thalassemia, 1 case with α and β thalassemia), Hb G-Honolulu in 3 cases(1 case with α thalassemia), Hb J-Bangkok in 2 cases(2 cases with α thalassemia), Hb Osu-Christiansborg in 1 case(with α thalassemia), Hb Hasharon in 1 case(with α thalassemia), Hb Koln in 1 case(with α thalassemia).
CONCLUSION: The incidence of abnormal hemoglobin diseases in Guangzhou area has been found to be more high, 8 kinds of abnormal hemoglobin are found by HPLC, the HPLC is an effective way to screen the couples of childbearing age for β thalassemia and hemoglobinopathies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29262913     DOI: 10.7534/j.issn.1009-2137.2017.06.034

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  1 in total

1.  Importance of DNA Sequencing for Abnormal Hemoglobins Detected by HPLC Screening

Authors:  Duran Canatan; Abdullah Çim; Serpil Delibaş; Emel Altunsoy; Serdar Ceylaner
Journal:  Turk J Haematol       Date:  2020-03-04       Impact factor: 1.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.